Please use this identifier to cite or link to this item: http://hdl.handle.net/11455/81158
DC FieldValueLanguage
dc.contributor洪慧芝zh_TW
dc.contributor.author張明傑zh_TW
dc.contributor.authorChang, Ming-Jieen_US
dc.contributor.other生命科學院碩士在職專班zh_TW
dc.date2012en_US
dc.date.accessioned2014-06-13T08:11:05Z-
dc.date.available2014-06-13T08:11:05Z-
dc.identifierU0005-2308201210514300en_US
dc.identifier.citation參考文獻 Andrade F, Darrah E, Gucek M, Cole RN, Rosen A, Zhu X. (2010) Autocitrullination of human peptidylarginine deiminase 4 regulates protein citrullination during cell activation. Arthritis Rheum 62(6):1630-1640 Arita K, Hashimoto H, Shimizu T, Nakashima K, Yamada M, Sato M. (2004) Structural basis for Ca2+-induced activation of human PAD4. Nat Struct Mol Biol 11(8):777-783 Agrawal S, Misra R, Aggarwal A. (2007) Autoantibodies in rheumatoid arthritis: association with severity of disease in established RA. Clin Rheumatol 26:201-204 Alivernini S, Fedele AL, Cuoghi I, Tolusso B, Ferraccioli G. (2008) Citrullination: the loss of tolerance and development of autoimmunity in rheumatoid arthritis. Reumatismo 60:85-94 Balitskaia OV, Berdinskikh NK, Kononenko NG. (1992) The possibilities of using the free polyamines of the peripheral blood as biochical tumor markers in nephroblastoma in children. Vopr Onkol 38(6):674-682 Basu PS, Majhi R, Ghosal S, Batabyal SK. (2011) Peptidyl-arginine deiminase: an additional marker of rheumatoid arthritis. Clin Lab 57(11-12):1021-5 Balbo PB, Patel CN, Sell KG, Adcock RS, Neelakantan S, Crooks PA, Oliveira MA. (2003) Spectrophotometric and steady-state kinetic analysis of biosynthetic arginine decarboxylase of yersinia pestis utilizing arginine analogues as inhibitors and alternative substrates. Biochemistry 42(51):15189-15196 Brown PH, Schuck P. (2006) Macromolecular size-and-shape distributions by sedimentation velocity analytical ultracentrifugation. Biophys J 90(12):4651-4661 Cafaro TA, Santo S, Robles LA, Crim N, Urrets-Zavalia JA, Serra HM. (2010) Peptudylarginine deiminase type 2 is over expressed in the glaucomatous optic nerve. Mol Vis 16:1654-8 Chang X, Yamada R, Suzuki A, Sawada T, Yoshino S, Tokuhiro S, Yamamoto K. (2005) Localization of peptidylarginine deiminase 4 (PADI4) and citrullinated protein in synovial tissue of rheumatoid arthritis. Rheumatology 44:40-50 Chang X, Han J. (2006) Expression of pepetidylarginine deiminase type 4 (PAD4) in various tumors. Molecular Carcinogenesis 45(3):183-96 Chang X, Zhao Y, Sun S, Zhang Y, Zhu Y. (2009) The expression of PADI4 in synovium of rheumatoid arthritis. Rheumatology International 29:1411-1416 Chavanas S, Mechin MC, Takahara H, Kawada A, Nachat R, Serre G Simon M. (2004) Comparative analysis of the mouse and human peptidylarginine deiminase gene clusters reveals highly conserved non-coding segments and a newhuman gene, PADI6. Gene 330:19-27 Coffino P. (2001) Antizyme, a mediator of ubiqutin-independent proteasomal degradation. Biochimie 83:319-323 Daigle ND, Carpentier GA, Frenette-Cotton R, Simard MG, Lefoll MH, Noel M, Caron L, Noel J, Isenring P. (2009) Molecular characterization of a human cation-Cl-cotransporter (SLC12A8A, CCC9A) that promotes polyamine and amino acid transport. J Cell Physiol 220(3):680-689 Foulquier C, Sebbag M, Clavel C, Chapuy-Regaud S, Al Badine R, Mechin MC, Vincent C, Nachat R, Yamada M, Takahara H, Simon M, Guerr M, Serre G. (2007) Peptidylarginine deiminase type 2 (PAD-2) and PAD-4 but not PAD-1, PAD-3, and PAD-6 are expressed in rheumatoid arthritis synovium in close association with tissue inflammation. Arthritis Rheum 56(11):3541-53 Gueerin M, Ishigami A, Mechin MC, Nachat R, Valmary S, Sebbag M, Simon M, Senshu T, Serre G. (2003) cDNA cloning, gene organization and expression analysis of human peptidylarginine deiminase type I. Biochem J 370(Pt 1):167-74 Hagiwara T, Nakashima K, Hirano H, Senshu T, Yamada M. (2002) Deimination of argine residues in nucleophosmin/B23 and histones in HL-60 granulocytes. Biochem Biophys Res Commun 290(3):979-983 Hayashi S, Murakami Y. (1995) Rapid and regradation of orithine decarboxy. Biochem J 306:1-10 Heller JS, Fong WF, Canellakis ES. (1976) Induction of a protein inhibitor to ornithine decarboxylase by the end products of its reaction. Proc Natl Acad Sci USA 73:1858-1862 Ivanov IP, Rohrwasser A, Terreros DA, Gesteland RF, Atkins JF. (2000b) Discovery of a spermatogenesis stage-specific ornithine decarboxylase antizyme: Antizyme 3. Proc Natl Acad Sci USA 97:4808-4813 Kanno T, Kawada A, Yamanouchi J, Yosida-Noro C, Yoshiki A, Shiraiwa M, Kusakabe M, Manabe M, Tezuka T, Takahara H. (2000) Human peptidylarginine deininase type Ⅲ: Molecular cloning and nucleotide sequence of the cDNA, properties of the recombinant enzyme, and immunohistochemical localization in human skin. Journal of Investigative Dermatology 115:813-823 Kearney PL, Bhatia M, Jones NG, Yuan L, Glascock MC, Catchings KL, Yamada M, Thompson PR. (2005) Kinetic characterization of protein arginine deiminase 4: a transcriptional corepressor implicated in the onset and progression of rheumatoid Arthritis. Biochemistry 44(31):10570-82 Lambert C, Leonard N, De Bolle X, Depiereux E. (2002) ESyPred3D: Predicition of proteins 3D structures. Bioinformatics 18:1250-1256 Liao YF, Hsieh HC, Liu GY, Hung HC. (2005) A continuous spectrophotometric assay method for peptidylarginine deiminase type 4 activity. Anal Biochem 347(2):176-81 Matsufuji S, Matsufuji T, Miyazaki Y, Murakami Y, Atkins JF, Gesteland RF, Hayashi S. (1995) Autoregulatory frameshifting in decoding mammalian ornithine decarboxylase antizzyme. Cell 80:51-60 Nakashima K, Hagiwara T, Yamada M. (2002) Nuclear localization of peptidylarginine deiminase Ⅴ and histone deimination ingranulocytes. J Biol Chem 277(51):49562-49569 Pegg AE. (2006) Regulation of ornithine decarboxylase. J Biol Chem 281(21):14529-32 Pollastri G, McLysaght A. (2005) Porter: a new, accurate sever gor protein secondary structure predicition. Bioinformatics 21:1719-1720 Rogers GE, Harding HW, Llewllyn-Smith JJ. (1977) The origin of citrulline-containing proteins in the hair follicle and the chemical nature of trichoyalin, an intracellular precursor. Biochim Biophys Acta 495(1):159-75 Sakata K, Kashiwagi K, Igarashi K. (2000) Properties of a polyamine transporter regulated by antizyme. Biochem J 347(Pt 1):297-303 Suzuki A, Yamada R, Chang X, Tokuhiro S, Sawada T, Suzuki M, Nagasaki M, Nakayama-Hamada M, Kawaida R, Ono M, Ohtsuki M, Furukawa H, Yoshino S, Yukioka M, Tohma S, Matsubara T, Wakitani S, Teshima R, Nishioka Y, Sekine K, Iida A, Takahashi A, Tsunoda T, Nakamura Y, Yamamoto K. (2003) Functional haplotypes of PADI4, encoding citrullinating enzyme peptidylarginine deiminase 4, are associated with rheumatoid arthritis. Nat Genet 34:395-402 Tarcsa E, Marekov LN, Mei G, Melino G, Lee SC, Steinert PM. (1996) Protein unfolding by peptidylarginine deiminase. Substrate specificity and structural relationships of the natural substrates trichohylin and filaggrin. J Bio Chem 271(48):30709-16 Vossenaar ER, Zedman AJ, van Venrooij WJ, Pruijn GJ. (2003) PAD, a growing family of citrullinating enzyme: genes, features and involvement in disease. Bioessays 25(11):1106-18 Zhang J, Dai J, Zhao E, Lin Y, Zeng L, Chen J, Zheng H, Wang Y, Li X, Ying K, Xie Y, Mao Y. (2004) cdna cloning, gene organization and expression analysis of human peptidylargininedeiminase type VI.Acta Biochim Pol. 51(4):1051-8.en_US
dc.identifier.urihttp://hdl.handle.net/11455/81158-
dc.description.abstract人類胜肽精胺酸去亞胺酶 (human peptidylarginine deiminase,PAD) 是一種將蛋白質轉譯後修飾的酵素,能夠將目標蛋白上的精胺酸 (arginine) 轉變成瓜胺酸 (citrulline),而此反應稱之為protein citrullination (deimination)。胜肽精胺酸去亞胺酶總共有五種異構型 (isoforms),而第四型胜肽精胺酸以同源雙套體形式存在人體內,需要鈣離子才會有酵素活性。近年來第四型胜肽精胺酸去亞胺酶也被認為是研究類風濕性關節炎的重要蛋白,根據研究此蛋白會催化多種受質蛋白,引發人體相關免疫疾病;而近期也陸續發現第四型胜肽精胺酸去亞胺酶會在多種癌症和惡性腫瘤組織裡有大量表現,與細胞凋亡和細胞周期的停止有密切關係;為了探討第四型胜肽精胺酸去亞胺酶與疾病相關蛋白間的作用,純化與抗酶 (Antizyme,AZ) 疾病相關的蛋白,利用酵素動力學的方式測其第四型胜肽精胺酸去亞胺酶酵素活性,結果顯示與抗酶作用後具有活性並且得知R42、R81、R86、R100、R188及R199受到脫胺作用,故推測抗酶可能是第四型胜肽精胺酸去亞胺酶之受質;而抗酶在細胞內主要透過結合人類鳥胺酸脫羧酶 (Ornithine decarboxylase, hODC) 來調控多胺之濃度,因此探究其抗酶受到第四型胜肽精胺酸去亞胺酶脫胺後之功能,由培養脫胺後與多點突變型之結果皆能發現抗酶會降低抑制人類鳥胺酸脫羧酶的能力,得知抗酶受到第四型胜肽精胺酸去亞胺酶脫胺後會改變其原本生理功能。經由探討兩者間交互作用的影響,了解第四型胜肽精胺酸去亞胺酶在抗酶調控ODC表現中所扮演的角色。zh_TW
dc.description.abstractThe peptidylarginine deminase (PAD) family is a kind of post-translational modifying enzyme that can catalyes protein citrullination (deimination) which is the conversion of protein-bound arginine to citrulline (Arg -> Cit). PAD4, one of the PAD isoform family, which is a dimeric enzyme catalyes protein in the presence of calcium. PAD4 is considered as the important enzyme for rheumatoid arthritis in the past few years. According to the research, PAD4 will initiate immunity of this disease. PAD4 recently has been found to overexpress in many cancers and malignant tissues that closely related to the apoptosis and cell cycle arrest. In order to explore the PAD4 between the role of the enzyme and disease-related role, we have purified a variety of disease-related protein to measure PAD4 enzyme activity by enzyme kinetics assay. The results showed that PAD4 can use antizyme (AZ) as the protein substrate and the kinetic data showed that R42, R81, R86, R100, R188 and R199 are critical residues to be citrullinated in AZ. For this reason, we suggested that AZ may be as a substrate for PAD4. However, AZ mainly combinated with human ornithine decarboxylase (hODC) to regulate the concentrations of polyamine in cells. Our data showed that incubation of AZ with PAD4 and multisite mutations will reduce the ability to inhibit ODC activity. Therefore, we could know that PAD4 may change AZ founction after AZ citrullination. By according to these results, we propose that PAD4 may play an important role in the regulation of AZ of ODC activity.en_US
dc.description.tableofcontents目次 中文摘要 I 英文摘要 II 目次 III 縮寫表 IV 表目次 V 圖目次 VI 一、前言 1 二、實驗方法 5 三、結果 13 四、討論 19 五、結論 22 參考文獻 23 表 28 圖 34 附 錄 52 實驗材料 53 主要儀器與器材 55 相關藥品配置 58zh_TW
dc.language.isozh_TWen_US
dc.publisher生命科學院碩士在職專班zh_TW
dc.relation.urihttp://www.airitilibrary.com/Publication/alDetailedMesh1?DocID=U0005-2308201210514300en_US
dc.subject胜肽精胺酸去亞胺酶抗酶瓜胺酸化zh_TW
dc.subjectPAD4en_US
dc.subjectAZen_US
dc.subjectcitrullinationen_US
dc.title確認人類胜肽精胺酸去亞胺酶第四型對抗酶脫胺的位置與功能zh_TW
dc.titleIdentification of citrullination sites of antizyme by peptidylarginine deiminase 4en_US
dc.typeThesis and Dissertationzh_TW
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.openairetypeThesis and Dissertation-
item.cerifentitytypePublications-
item.fulltextwith fulltext-
item.languageiso639-1zh_TW-
item.grantfulltextrestricted-
Appears in Collections:生命科學院
Files in This Item:
File SizeFormat Existing users please Login
nchu-101-7099052061-1.pdf1.48 MBAdobe PDFThis file is only available in the university internal network    Request a copy
Show simple item record
 
TAIR Related Article

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.